Revolutionizing the Way CRISPR is Used in Plants


Next-generation genomics achieves morphine pathway removal for poppy cultivation and drug development.


Our Science


Employing our patented gene editing processes together with CRISPR technology and cutting-edge farming practices, Emerzene has developed a non-addictive strain of poppy.

We are now able to produce a line of plant-based, morphine-free pain medications to be part of the solution to drug abuse and dependence.

Image

What is CRISPR?

Born to solve global food crisis’, plant disease problems, and world-wide agricultural challenges, Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR) genome-editing technology opens new opportunities to engineer disease resistant cultivation and solve major challenges in crop improvement.

CRISPR technology has been successfully used to engineer plants and crops resistant to bacteria, viruses, fungi, and pests. Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology enables development and improvement of critical crops characteristics.

PARTNER WITH US


A Specific, Efficient and Versatile Tool for Editing Genes


Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology is able to develop crops that contain all critical characteristics.


Image


CRISPR Applied to Plant-Based Medicine


Searching for a breakthrough in pain relief, Emerzene experts utilized CRISPR mediated genome editing to engineer a unique strain of poppy (P. Bracteatum). Our proprietary poppy strain contains elements needed to product the first ever all-natural, non-addictive pain relief medication.

Image

Key advantages include:

  • The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.

  • Thanks to CRISPR technology, P bracteatum poppy strain is resistant to diseases that plague normal poppy plantations. This diminishes or eliminates the need for chemical or cultural control measures.

  • By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, we can produce a complete non-addictive form of poppy extract without a morphine pathway.

  • Our extraction methods use water, in place of chemicals, maximizing extraction and production of all natural chemical free extracts.



Key advantages include:

  • The traditional poppy plant is seasonal, requiring annual planting and cultivation. Our unique strain is perennial, thereby reducing management processes, resulting in lower costs and minimizing environmental disruptions.

  • Thanks to CRISPR technology, P bracteatum poppy strain is resistant to diseases that plague normal poppy plantations. This diminishes or eliminates the need for chemical or cultural control measures.

  • By selecting desired traits within the poppy plant, and utilizing CRIPSR technology to modify genomes within the plant, we can produce a complete non-addictive form of poppy extract without a morphine pathway.

  • Our extraction methods use water, in palace of chemicals, maximizing extraction and production all natural chemical free extracts.



Our solvent-free extraction

and API manufacturing is being contracted to an established GMP certified facility in Liechtenstein, Europe.

Image

We are actively looking to partner with pharmaceutical companies for our R&D trials to propel the next generation of medicinal advances.


PARTNER WITH US


Image

© 2024 Emerzene. All rights reserved.
Design by Bhakti Creative.